Efficacy of Immunotherapy With TG4040, Peg-Interferon, and Ribavirin in a Phase 2 Study of Patients With Chronic HCV Infection-Reference-Cited by-同舟云学术

Efficacy of Immunotherapy With TG4040, Peg-Interferon, and Ribavirin in a Phase 2 Study of Patients With Chronic HCV Infection

Published:2014-07 Issue:1 Volume:147 Page:119-131.e3
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Di Bisceglie Adrian M.,Janczweska–Kazek Ewa,Habersetzer François,Mazur Wlodzimierz,Stanciu Carol,Carreno Vicente,Tanasescu Coman,Flisiak Robert,Romero–Gomez Manuel,Fich Alexander,Bataille Vincent,Toh Myew–Ling,Hennequi Marie,Zerr Patricia,Honnet Géraldine,Inchauspé Geneviève,Agathon Delphine,Limacher Jean–Marc,Wedemeyer Heiner

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference34 articles.

1. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence;Mohd Hanafiah;Hepatology,2013

2. The global burden of hepatitis C;Lavanchy;Liver Int,2009

3. Management of hepatitis C virus infection;J Hepatol,2011

4. Antiviral strategies in hepatitis C virus infection;Sarrazin;J Hepatol,2012

5. New protease inhibitors and direct-acting antivirals for hepatitis C: interferon's long goodbye;Dusheiko;Gut,2012

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C Vaccines;Plotkin's Vaccines;2023

2. Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection;Cancer Prevention Research;2022-12-06

3. Construction and Evaluation of Traceable rhES-QDs-M-MS Protein Delivery System: Sustained-Release Properties, Targeted Effect, and Antitumor Activity;AAPS PharmSciTech;2022-07-28

4. Viral Delivery of IL-7 Is a Potent Immunotherapy Stimulating Innate and Adaptive Immunity and Confers Survival in Sepsis Models;The Journal of Immunology;2022-07-01

5. Application of real-time PCR to significantly reduce the time to obtain recombinant MVA virus;Journal of Virological Methods;2021-03